Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Plantar Fasciitis: full-pipeline trial registry
2 of 7 indexed Plantar Fasciitis trials are currently recruiting.
Corpus placement: #2,497 of 28,707 conditions by registered trial count.
7 US clinical trials · 2 currently recruiting · #2,497 of 28,707 conditions by registered trial count
Plantar Fasciitis: 7 US clinical trials tracked, 2 recruiting.
Plantar Fasciitis is the subject of 7 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is Revance Therapeutics, running 2 of these trials.
Enrollment posture brief
Registry condition plantar-fasciitis
OPEN 2 | RECR 29% | LATE 2 | EARLY 3 | RANK #2497 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Acromegaly (29% recruiting · 14 trials)
Plantar Fasciitis lists 2 open slots (29% of 7 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Plantar Fasciitis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Plantar Fasciitis is recruiting below its size-band peers.
2 of 7 indexed trials (28.6%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Plantar Fasciitis research.
Revance Therapeutics accounts for 2 of 7 trials (28.6%). 6 distinct sponsors appear on at least one study for this condition label.
-
Most Plantar Fasciitis trials plan to enrol fewer than 100 people.
Median target enrolment is 60 among the 7 trials that report a genuine target (sentinel values excluded). 5 of those (71.4%) plan for fewer than 100 participants.
-
Plantar Fasciitis research is mostly interventional.
7 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
7 total, page 1 of 1
The Effects of Terrain Variation on Intrinsic Foot Musculature in Healthy Individuals and Individuals With Plantar Fasciitis
University of Florida
NCT05075005
Lateral Plantar Artery Embolization For Plantar Fasciitis
Joint & Vascular Institute
NCT07395128
Study of Effectiveness and Safety of Extracorporeal Shock Wave Therapy (ESWT) for Treatment of Painful Heel Syndrome
Storz Medical
NCT00720694
DaxibotulinumtoxinA for Injection for the Treatment of Plantar Fasciitis
Revance Therapeutics
NCT03825315
Treatment of Plantar Fasciitis With Dorsiflexion Night Splints and Medial Arch Supports
University of Pittsburgh
NCT00222911
Phase 2 DaxibotulinumtoxinA for Injection for the Management of Plantar Fasciitis
Revance Therapeutics
NCT03137407
Comparative Study of Amniotic Membrane Injectable in the Treatment of Recalcitrant Plantar Fasciitis
MiMedx Group
NCT01659827
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 2 |
| Phase 3 | 1 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Plantar Fasciitis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Plantar Fasciitis trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Plantar Fasciitis page
7 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Plantar Fasciitis trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Revance Therapeutics sponsors the most Plantar Fasciitis trials on record, review their full trial history before evaluating a specific study. See Revance Therapeutics's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Plantar Fasciitis condition card totals 7 registered trials; most-linked intervention 1.25cc AmnioFix; top US site state Illinois. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.